Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress-Responsive Activation of PERK Signaling.

Angewandte Chemie
Young-Hee ShinSeung Bum Park

Abstract

Tau protein aggregates are a recognized neuropathological feature in Alzheimer's disease as well as many other neurodegenerative disorders, known as tauopathies. The development of tau-targeting therapies is therefore extremely important but efficient strategies or protein targets are still unclear. Here, we performed a cell-based phenotypic screening under endoplasmic reticulum (ER) stress conditions and identified a small molecule, SB1617, capable of suppressing abnormal tau protein aggregation. By applying label-free target identification technology, we revealed that the transient enhancement of protein kinase-like endoplasmic reticulum kinase (PERK) signaling pathway through the inhibition of stress-responsive SB1617 targets, PDIA3 and DNAJC3, is an effective strategy for regulating proteostasis in tauopathies. The molecular mechanism and the promising efficacy of SB1617 were demonstrated in neuronal cells and a mouse model with traumatic brain injury, a tauopathy known to involve ER stress.

References

Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Nov 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Wei YanMichael G Katze
Jan 4, 2003·Nature Reviews. Neuroscience·Claudio Soto
Jun 21, 2007·The Journal of Biological Chemistry·Serhiy PankivTerje Johansen
Mar 24, 2009·Nature Methods·Enrico K SchmidtPhilippe Pierre
Nov 17, 2010·Nature Chemical Biology·Benjamin G HoffstromBrent R Stockwell
Mar 9, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Emanuela CollaMichael K Lee
Nov 17, 2012·Neurochemistry International·István FöldiTamás Janáky
Jun 28, 2013·Nucleic Acids Research·Wafa B'chirAlain Bruhat
Oct 14, 2014·Journal of the American Chemical Society·Jonghoon KimSeung Bum Park
Jan 15, 2015·Neuromolecular Medicine·Vardit RubovitchChaim G Pick
Feb 24, 2015·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Andrea LinzRita Dreier
Apr 8, 2015·Proceedings of the National Academy of Sciences of the United States of America·Anna KaplanBrent R Stockwell
Jul 1, 2015·Nature Cell Biology·Claudio HetzScott A Oakes
Jul 15, 2015·The Journal of Biological Chemistry·Mauricio TorresClaudio Hetz
Sep 12, 2015·PloS One·Valentina CastilloClaudio Hetz
Dec 4, 2015·Nature Reviews. Neuroscience·Yipeng Wang, Eckhard Mandelkow
Dec 5, 2015·Nature Reviews. Neurology·Khalid IqbalCheng-Xin Gong
Apr 5, 2016·Chemical Communications : Chem Comm·Hankum ParkSeung Bum Park
Aug 6, 2016·Biochemical and Biophysical Research Communications·George EdwardsClaudio Soto
Oct 21, 2016·Neuron·Cristian A Lasagna-ReevesHuda Y Zoghbi
Jul 21, 2017·Pharmacology & Therapeutics·Aubryanna HettinghouseChuan-Ju Liu
Jul 22, 2017·Nature Reviews. Neurology·Claudio Hetz, Smita Saxena
Jan 13, 2018·Frontiers in Cellular Neuroscience·Priyamvada M PitaleMarina Gorbatyuk
Feb 6, 2018·EBioMedicine·Jaime Ramos-CejudoSilvia Fossati
Jun 14, 2018·Nature Reviews. Neurology·Erin E Congdon, Einar M Sigurdsson
Feb 19, 2019·Journal of Alzheimer's Disease : JAD·Nadia I BocaiEduardo M Castaño

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electrophoresis
surface plasmon resonance spectroscopy

Software Mentioned

CETSA

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Related Papers

Trends in Endocrinology and Metabolism : TEM
T Kelly RainboltRockland Luke Wiseman
Biochemical and Biophysical Research Communications
Yukako SakagamiMasatoshi Takeda
CNS & Neurological Disorders Drug Targets
Nahuai BadiolaAlberto Lleó
Seminars in Neurology
Farwa Ali, Keith A Josephs
Neuropharmacology
Thomas W RöslerGünter U Höglinger
© 2021 Meta ULC. All rights reserved